DISCOVERY OF ANTITOXINS AND DEVELOPMENT OF ANTIBODY PREPARATIONS FOR CLINICAL USES FROM 1890 TO 1990

被引：29

作者：

GRONSKI, P ^{[1
]}

SEILER, FR ^{[1
]}

SCHWICK, HG ^{[1
]}

机构：

[1] BEHRINGWERKE AG,IMMUNOL RES DEPT,RES LABS,POB 1140,W-3550 MARBURG,GERMANY

来源：

MOLECULAR IMMUNOLOGY | 1991年 / 28卷 / 12期

关键词：

D O I：

10.1016/0161-5890(91)90034-H

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

[No abstract available]

引用

页码：1321 / 1332

页数：12

共 108 条

[31]

GRONSKI P, 1988, BEHRING I MITT, V82, P144

[32]

GRONSKI P, 1990, BEHRING I MITT, V86, P185

[33]

Gronski P., 1988, BEHRING I MITT, V82, P127

[34] THE GAMMA-GLOBULINS AND THEIR CLINICAL SIGNIFICANCE .4. THERAPEUTIC USES OF GAMMA-GLOBULINS [J].

GROSS, PAM ;

GITLIN, D ;

JANEWAY, CA .

NEW ENGLAND JOURNAL OF MEDICINE, 1959, 260 (04) :170-178

[35]

HAASE M, 1983, IMMUN INFEKT, V11, P135

[36] ISOLATION AND CHARACTERIZATION OF ANTIGENIC COMPONENTS OF A NEW HEPTAVALENT PSEUDOMONAS VACCINE [J].

HANESSIAN, S ;

REGAN, W ;

WATSON, D ;

HASKELL, TH .

NATURE-NEW BIOLOGY, 1971, 229 (07) :209-+

[37]

Hansen A., 1938, BIOCHEMISTRY-US, V299, P377

[38] S-SULFONATION - A REVERSIBLE CHEMICAL MODIFICATION OF HUMAN-IMMUNOGLOBULINS PERMITTING INTRAVENOUS APPLICATION .2. EFFECT ON FC-MEDIATED EFFECTOR FUNCTIONS [J].

HOFSTAETTER, T ;

GRONSKI, P ;

KANZY, EJ ;

SCHORLEMMER, HU ;

SEILER, FR .

VOX SANGUINIS, 1983, 45 (02) :155-165

[39]

HOMMA JY, 1980, JPN J EXP MED, V50, P149

[40]

HOPPE JY, 1979, BLUT, V39, P9

← 1 2 3 4 5 6 7 8 9 10 →